Clinical Trial Update: Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating docetaxel and erlotinib in older patients with prostate cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• ERLOTINIB (Erlotinib)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED